You're entirely right. In English, you call that a rocket docket, which basically means a simplified procedure.
You have to understand that we're talking about counterfeit pharmaceuticals here. It is relatively easy to demonstrate whether or not a pharmaceutical is a counterfeit. Sometimes, the indicators are not so much for public consumption, but it is not really that hard to demonstrate that a pharmaceutical product is a fake. So this may be a potential solution in order to simplify the process when it comes to counterfeits. We're not talking about full-blown violations here, but about something that is similar, without being identical.
I'm a little bit concerned about today's testimony. You have before you two gentlemen arguing different points of view, but the problem is that we're not necessarily talking about the same things.
I'm talking about counterfeit pharmaceuticals that are trademarked; I'm not referring to a grand-mother using Wi-Fi, etc. When you consider the testimony, you should perhaps bear this difference in mind.
Furthermore, if dealing with counterfeiting involves amending legislation, not only the Copyright Act would need to be amended. It would have to be a different piece of legislation which dealt specifically with counterfeiting. This would ensure other areas wouldn't be encroached upon.